The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.76
Bid: 40.86
Ask: 40.92
Change: -1.50 (-3.55%)
Spread: 0.06 (0.147%)
Open: 41.50
High: 41.60
Low: 40.54
Prev. Close: 42.26
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

5 Oct 2022 07:00

RNS Number : 7831B
Assura PLC
05 October 2022
 

5 October 2022

Assura plc

 

Trading Update

For the first half ending 30 September 2022

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first half of the year to 30 September 2022.

 

Jonathan Murphy, CEO, said:

"Following another period of good progress, Assura continues to be well positioned to meet the UK's strong underlying demand for quality primary care and community health buildings as a partner of choice for the NHS.

"Highly targeted and selective acquisitions and developments during the first half of the year, along with the disposal of 61 properties for £73 million, have further strengthened the quality of our portfolio, which now stands at 603 properties with an annual rent roll of £139 million and a weighted average unexpired lease term of 11.4 years.

"Our financial position remains very strong. Our debt book is fixed at an average interest rate of 2.3% with a long-term average maturity of 7.5 years, and we have cash and committed undrawn facilities totalling £284 million.

"Together with the strength of our portfolio and expertise of our teams, we are well placed to take advantage of the opportunities ahead. That said, we recognise the current macro-economic uncertainty and industry-wide inflationary pressure and will continue to monitor and take a cautious approach to capital investment to ensure long-term success."

 

Strong track record of disciplined investment alongside ongoing capital recycling

· Portfolio currently stands at 603 properties with an annualised rent roll of £139.3 million

· Invested £141 million on additions during the half at an average yield on cost of 5.0%; six development completions, 13 acquisitions and three assets in co-investment arrangements, largely in the first quarter

· Three developments started on site, including our first net zero carbon project in Fareham

· Completed disposal of portfolio of 61 properties for £73 million at a small premium to book value

· Seven lease regears completed (£1.1 million of existing rent)

· Completed five asset enhancement capital projects (total spend £2.2 million); on site with a further six (total spend £8.8 million)

 

Development and acquisition pipelines provide growth opportunities

· Currently on site with 13 developments; total cost of £153 million (March 2022: 17, £166 million) of which £65 million has been spent to date

· Immediate development pipeline of 10 schemes, where we would normally expect to be on site within 12 months; total cost of £83 million (March 2022: 20, £158 million). We continue to experience some delays to construction timetables and start dates

· Monitoring the extended development and acquisition pipelines as well as the immediate development pipeline in light of the current macro-economic environment

· 35 lease re-gears covering £6.4 million of existing rent roll in the current pipeline

· Pipeline of 18 capital asset enhancement projects (projected spend £10.5 million) over the next two years

 

Strong and sustainable financial position

· At 30 September 2022 net debt stood at £1,092 million with cash and undrawn facilities of £284 million

· All drawn facilities are unsecured with fixed interest (weighted average interest rate of 2.3%) and weighted average maturity 7.5 years

 

 

- ENDS -

 

 

 

 

Assura plc Jayne Cottam, CFO David Purcell, Investor Relations Director

Tel: 01925 945354 Email: Investor@assura.co.uk

 

FGS Global

Gordon SimpsonJames Thompson

 

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

 

 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

 

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2022, Assura's portfolio was valued at £2,752 million.

 

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

 

Further information is available at www.assuraplc.com

 

Assura plc LEI code: 21380026T19N2Y52XF72

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIDIVLSIIF
Date   Source Headline
16th Nov 20177:02 amRNSProposed Share Issue and Notice of GM
16th Nov 20177:00 amRNSInterim Results 2017
1st Nov 201711:24 amRNSTotal Voting Rights
20th Oct 201712:24 pmRNSNote issuance and increased debt facilities
18th Oct 201710:00 amRNSNotice of Results
16th Oct 20177:00 amRNSScrip Dividend Declaration
10th Oct 20177:00 amRNSAppointment of Non-Executive Director
3rd Oct 20173:01 pmRNSDirectorate Change
2nd Oct 20171:07 pmRNSNotification of Major Interests in Shares
2nd Oct 20177:00 amRNSTrading Update
25th Sep 20177:00 amRNSChief Financial Officer
21st Sep 201712:21 pmRNSScrip Calculation Price
11th Sep 20174:23 pmRNSNotification of Major Interests in Shares
8th Sep 20175:20 pmRNSPDMR Notification
7th Sep 20177:00 amRNSNotice of Dividend - Property Income Distribution
1st Sep 201711:42 amRNSTotal Voting Rights
1st Sep 201710:30 amRNSExercise of Nil Cost Options under VCP
30th Aug 20177:00 amRNSAdditional Listing
21st Aug 20171:44 pmRNSAppointment of Joint Corporate Broker
17th Aug 201712:05 pmRNSNotification of Major Interest in Shares
4th Aug 20177:00 amRNSAppointment of Chief Financial Officer
1st Aug 20177:00 amRNSTotal Voting Rights
19th Jul 20174:41 pmRNSNotification of Transactions by PDMRs
18th Jul 20172:27 pmRNSResult of AGM
18th Jul 20177:00 amRNSTrading Update
17th Jul 20177:00 amRNSScrip Dividend Declaration
3rd Jul 20179:20 amRNSCorrection of Total Voting Rights
3rd Jul 20177:00 amRNSTotal Voting Rights
22nd Jun 201711:14 amRNSScrip Calculation Price
22nd Jun 201710:14 amRNSNotification of Major Interests in Shares
22nd Jun 201710:11 amRNSNotification of Major Interests in Shares
20th Jun 20174:52 pmRNSResults of Placing
20th Jun 20177:00 amRNSProposed equity Issue of new ordinary shares
16th Jun 20174:00 pmRNSAnnual Report and Notice of AGM
16th Jun 20173:12 pmRNSNotification of Major Interests in Shares
13th Jun 20172:56 pmRNSNotification of Major Interests in Shares
8th Jun 20177:00 amRNSNotice of Dividend
5th Jun 20174:55 pmRNSNotification of transaction by PDMR
30th May 20177:00 amRNSDirector Declaration
24th May 201711:29 amRNSCorrection of Dividend Information
23rd May 20177:00 amRNSAssura Full Year Results
12th May 201711:00 amRNSNotification of Major Interests in Shares
11th May 20172:46 pmRNSNotification of Major Interests in Shares
2nd May 20177:00 amRNSTotal Voting Rights
18th Apr 20177:00 amRNSScrip Dividend Declaration
11th Apr 20174:29 pmRNSNotification of Major Interest in Shares
24th Mar 20174:15 pmRNSScrip Calculation Price
9th Mar 20177:00 amRNSNotice of Dividend
27th Feb 20177:00 amRNSAppointment of CEO
17th Feb 20173:07 pmRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.